IGWM
AQST icon

ICA Group Wealth Management’s Aquestive Therapeutics AQST Stock Holding History

ICA Group Wealth Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$6.73K Buy
2,590
+1,040
+67% +$3.47K ﹤0.01% 542
2024
Q1 		$6.6K Buy
+1,550
New +$5.16K ﹤0.01% 979

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ICA Group Wealth Management's AQST Position: Q2 2024 in Review

ICA Group Wealth Management increased its Aquestive Therapeutics (AQST) stake by 67% in Q2 2024, buying an estimated $3.47K and bringing the position to 2,590 shares worth $6.73K. The position accounts for ﹤0.01% of the portfolio, ranked #542.

ICA Group Wealth Management first reported a position in AQST in Q1 2024 and has held it in 2 quarters since. 97 funds tracked by Wall St. Rank hold AQST as of Q2 2024.

  • ICA Group Wealth Management held 2,590 shares of Aquestive Therapeutics worth $6.73K as of Q2 2024.
  • ICA Group Wealth Management bought 1,040 Aquestive Therapeutics shares in Q2 2024, an estimated $3.47K.
  • Aquestive Therapeutics made up ﹤0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #542 holding.
  • ICA Group Wealth Management first reported a position in Aquestive Therapeutics in Q1 2024 and has held it in 2 quarters since.
  • 97 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.